RSSCategory: Recent News

Assuming the Role of NCI Director: Working to Accelerate Progress

| November 2, 2017 | 0 Comments

Assuming the Role of NCI Director: Working to Accelerate Progress Norman Sharpless, M.D., discusses his appointment as the director of the National Cancer Institute and his plans for continuing NCI’s long tradition of research excellence and commitment to improving people’s lives.See Original Article

Continue Reading

Glutamine, Cystine, and Cancer Susceptibilities

| October 30, 2017 | 0 Comments

Glutamine, Cystine, and Cancer Susceptibilities The rapid growth of cancer cells generates increased amounts of toxic reactive oxygen species (ROS). Four recent papers show how understanding how cancers deal with ROS can lead to therapeutic opportunities.See Original Article TMIST Trial Aims to Provide Clarity on Breast Cancer Screening Approaches A large nationwide clinical trial called […]

Continue Reading

Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer

| October 26, 2017 | 0 Comments

Abemaciclib Approved by FDA for Advanced or Metastatic Breast Cancer FDA approved abemaciclib (Verzenio™) for the treatment of some people with advanced or metastatic HR-positive, HER2-negative breast cancer whose disease has progressed after treatment with hormone therapy.See Original Article

Continue Reading

With FDA Approval for Advanced Lymphoma, Second CAR T-Cell Therapy Moves to the Clinic

| October 25, 2017 | 0 Comments

With FDA Approval for Advanced Lymphoma, Second CAR T-Cell Therapy Moves to the Clinic One month after approving the first CAR T-cell therapy for cancer, FDA has approved a second such therapy. The treatment, axicabtagene ciloleucel (Yescarta™), was approved for some patients with advanced non-Hodgkin lymphoma.See Original Article

Continue Reading

Study Uses Open Data to Analyze “Normal” Tissue Near Tumors

| October 23, 2017 | 0 Comments

Study Uses Open Data to Analyze “Normal” Tissue Near Tumors The tissue immediately surrounding a tumor may not be normal, even if it appears normal under the microscope, according to an analysis of data from two genomic databases suggests.See Original Article

Continue Reading

Nivolumab Receives Accelerated Approval from FDA for Advanced Liver Cancer

| October 20, 2017 | 0 Comments

Nivolumab Receives Accelerated Approval from FDA for Advanced Liver Cancer The FDA has granted accelerated approval to the immunotherapy drug nivolumab (Opdivo®) for patients with advanced liver cancer who have previously been treated with the targeted therapy sorafenib (Nexavar®).See Original Article

Continue Reading

Studies Identify Therapies That May Delay Melanoma Recurrence after Surgery

| October 19, 2017 | 0 Comments

Studies Identify Therapies That May Delay Melanoma Recurrence after Surgery Two recent clinical trials have identified treatments that may delay cancer from returning in some patients with melanoma. Patients in both trials had advanced melanoma that was surgically removed, and each trial tested different forms of post-surgical, or adjuvant, therapy.See Original Article

Continue Reading

Copanlisib Approved for Follicular Lymphoma

| October 16, 2017 | 0 Comments

Copanlisib Approved for Follicular Lymphoma FDA has granted accelerated approval to copanlisib (Aliquopa®) for the treatment of patients with follicular lymphoma, a form of non-Hodgkin lymphoma.See Original Article

Continue Reading

Pembrolizumab Secures FDA Approval in Stomach Cancer

| October 12, 2017 | 0 Comments

Pembrolizumab Secures FDA Approval in Stomach Cancer The FDA has granted accelerated approval to the immunotherapy drug pembrolizumab (Keytruda®) for use in patients with advanced gastric (stomach) cancer that is PD-L1 positive.See Original Article

Continue Reading

Extensive Lymph Node Removal Doesn't Improve Survival in Some Women with Early-Stage Breast Cancer

| October 10, 2017 | 0 Comments

Extensive Lymph Node Removal Doesn't Improve Survival in Some Women with Early-Stage Breast Cancer Long-term results from a large clinical trial confirm that, for some women with early-stage breast cancer who have lumpectomy as their surgical treatment, a less extensive lymph node biopsy approach is sufficient.See Original Article

Continue Reading